Blueweave
Clinical Trial Supplies Market Bwc20102

Clinical Trial Supplies Market Bwc20102

SPECIAL OFFER : 25% Super Discount For All !

Clinical Trial Supplies Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product (Manufacturing, Supply Chain Management, Logistics, Storage & Distribution, Others); By Clinical Phase (Phase I, Phase II, Phase III, Others); By Therapeutic Use (Oncology, CNS, Cardiovascular, Infectious Disease, Metabolic Disorders, Others); By End Use (Pharmaceutical, Biologics, Medical Device, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: February 2023
  • Report ID: BWC20102
  • Available Format: PDF
  • Page: 270

Report Overview

The rising burden of various chronic and communicable diseases and huge investments by pharmaceutical companies, governments, as well as research institutes in clinical trials are expected to drive global clinical trial supplies market during the forecast period between 2023 and 2029.

Global Clinical Trial Supplies Market - Industry Trends & Forecast Report, 2029

The global clinical trial supplies market size was estimated to be worth USD 2,090.2 million in 2022. During the forecast period between 2023 and 2029, the global clinical trial supplies market size is projected to grow at a CAGR of 5.09% reaching a value of USD 2,946.95 million by 2029. Major growth factors for the global clinical trial supplies market include the rising burden of various chronic and communicable diseases and huge investments by pharmaceutical companies, governments, as well as research institutes in clinical trials. The pharmaceutical and biotechnology companies are significantly investing in R&D activities for drug development which is expected to boost the global clinical trial supplies market during the forecast period.

Clinical Trial Supplies Market

Global Clinical Trial Supplies Market – Overview

Clinical trials are research projects conducted on human subjects to assess a therapeutic, surgical, or behavioral intervention. Clinical trials often fall into one of three categories: Interventional studies seek to learn more about a specific intervention or kind of treatment. Observational studies seek to understand how individuals behave in various contexts. Feasibility studies are intended to determine whether the primary research can be conducted. The provision of materials needed to execute a clinical trial is known as clinical supply or clinical trial supply. This includes the 24-hour collection and distribution of biological specimens (including infectious samples), experimental medications, kits, and other research materials and supplies, as well as knowledge and help.

Global Clinical Trial Supplies Market

Growth Drivers

Increasing Number of Clinical Trials

The rising number of clinical trials owing to the increasing burden of various chronic and infectious diseases is one of the major factors behind the growth of the global clinical trial supplies market. 440,140 trials are now listed on ClinicalTrials.gov, with sites in 221 nations and all 50 states of the United States. New medicines for many diseases, including cancer, heart disease, and asthma, have been made possible via clinical trials. These novel therapies could lengthen life, make some symptoms easier to control or lessen pain or impairment in certain patients.

Restraints

High Cost of Drug Development

Widespread worries about the rising costs of clinical trial implementation have an effect on the creation of new pharmaceuticals that are released onto the market. It is projected that it will cost between USD 161 million to USD 2.6 billion to launch a new medicine in the market. The majority of these high-expense estimates come from clinical studies. The drug development phases also involve excessive costs on the scale in different phases. For instance, the average estimated cost of Phase I drug development is USD 4 million, Phase II is USD 13 million, and Phase III is 20 million. High cost may act as a huge restraining factor for the growth of the global clinical trial supplies market.

Impact of COVID-19 on the Global Clinical Trial Supplies Market

COVID-19 elevated the critical nature of clinical trial supplies and their importance to the healthcare market. Although the global clinical trial supplies market was initially hindered during the pandemic period as the imposition of lockdowns in various countries halted the clinical trials of various therapeutic purposes, which significantly impacted the market growth. To complete vaccine development activities after the pandemic outbreak and stop any further human deaths, clinical trial sponsors, their clinical research organizations, study teams, and other important stakeholders, such as vendors, had to work cooperatively to secure clinical trial supplies.

Global Clinical Trial Supplies Market

Segmental Coverage

Global Clinical Trial Supplies Market – By Product

Based on product, the global clinical trial supplies market is segregated into manufacturing, supply chain management, logistics, storage & distribution, and other segments. The supply chain management segment holds the highest share of the global clinical trial supplies market. The disruptions brought by the pandemic boosted the need for efficient supply chain management to prevent any further disruptions in the trial that may delay life-changing treatments that patients need. The companies are extensively investing in improving supply chain management through cost-effective supply and distribution strategies laid out by experts in the field, which is anticipated to proliferate the market in the coming years.

Global Clinical Trial Supplies Market – By Clinical Phase

Based on the clinical phase, the global clinical trial supplies market is segmented into Phase I, Phase II, Phase III, and others. The Phase I segment accounts for the highest share of the market. The segment registered boisterous growth post the COVID-19 outbreak when the clinical trials for the vaccine development started in various countries to check its efficiency and safety on humans. Phase III is expected to register a high growth rate during the forecast period. Although the failure rate of drugs in Phase III is quite high due to nonconformity of safety standards, the need for qualifying this phase for drug launch is impacting its market growth.

Global Clinical Trial Supplies Market – By Therapeutic Use

Based on therapeutic use, the global clinical trial supplies market is segmented into oncology, CNS, cardiovascular, infectious disease, metabolic disorders, and others. The oncology segment holds the highest share in the global clinical trial supplies market. The growth of this segment is mainly attributed to the high and increasing burden of cancer worldwide. Clinical trials are how researchers decide whether new medicines are safe, efficient, and outperform existing ones. Clinical trials aid in the discovery of novel cancer detection and prevention strategies. Additionally, they assist in raising patients' quality of life both during and after therapy.

Global Clinical Trial Supplies Market – By End Use

Based on end use, the global clinical trial supplies market is segmented into pharmaceuticals, biologics, medical devices, and others. Pharmaceutical companies account for the highest market share owing to the increasing number of clinical trials for drug development. Pharmaceutical companies use clinical trial supplies for collection and delivery of biological specimens, investigational drugs, and others. However, the biologics segment is anticipated to gain high traction during the forecast period owing to extensive research activities around the development of drugs from biologics such as blood, proteins, viruses, or living organisms.

Global Clinical Trial Supplies Market – By Region

Geographically, the global clinical trial supplies market covers five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the global clinical trial supplies market which is attributed to the high concentration of global pharmaceutical giants including Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, and Merck & Co. The rising expenditure on R&D activities by these pharmaceutical companies. The Asia–Pacific region is projected to register the highest CAGR during the forecast period owing to the increasing number of healthcare companies conducting clinical trials in this region.

Competitive Landscape

Major players operating in the global clinical trial supplies market include Almac Group, Catalent, Inc., PCI Services, Parexel International Corporation, Sharp Packaging Services, Biocair, O&M Movianto, KLIFO A/S, Thermo Fisher Scientific, Inc., Movianto, Sharp, Catalent, Inc, Bionical Ltd., and Alium Medical Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In September 2022 – Parexel, US–based clinical research organization company, opened a new clinical trial supplies and logistics depot in Suzhou, China.

  • In July 2022 – Labcorp, a US–based healthcare company, expanded the production of specimen collection kit production at its plant in Belgium to meet growing demand in Europe, the Middle East, and Africa.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Product, Clinical Phase, Therapeutic use, End Use, Region

Key Players

Alamc Group, Catalent, Inc., PCI Services, Parexel International Corporation, Sharp Packaging Services, Biocair, O&M Movianto, KLIFO A/S, Thermo Fisher Scientific, Inc., Movianto, Sharp, Catalent, Inc, Bionical Ltd., Alium Medical Limited

 

 

By Product

  • Manufacturing

  • Supply Chain Management

  • Logistics

  • Storage & Distribution

  • Others

By Clinical Phase

  • Phase I

  • Phase II

  • Phase III

  • Others

By Therapeutic use

  • Oncology

  • CNS

  • Cardiovascular

  • Infectious Disease

  • Metabolic Disorders

  • Others

By End Use

  • Pharmaceutical

  • Biologics

  • Medical Device

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Clinical Trial Supplies Market Insights
    1. Industry Value Chain Analysis
      1. DROC Analysis
      2. Growth Drivers
        1. Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures
        2. Rising Burden of Chronic and Communicable Diseases
      3. Restraints
        1. Adverse Drug Reactions
      4.  Opportunities
        1. Rising New Drug Development Trial in Emerging Countries
      5. Challenges
        1. Impact of COVID-19 on Supply Chain
    2. Technology Advancements/Recent Developments
    3. Regulatory Framework
    4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Clinical Trial Supplies Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
        1. Manufacturing
        2. Supply Chain Management
        3. Logistics
        4. Storage & Distribution
        5. Others
      2. By Clinical Phase
        1. Phase I
        2. Phase II
        3. Phase III
        4. Others
      3. By Therapeutic use
        1. Oncology
        2. CNS
        3. Cardiovascular
        4. Infectious Disease
        5. Metabolic Disorders
        6. Others
      4. By End Use
        1. Pharmaceutical
        2. Biologics
        3. Medical Device
        4. Others
      5. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America
        5. Middle East and Africa (MEA)
  5. North America Clinical Trial Supplies Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Clinical Phase
      3. By Therapeutic use
      4. By End Use
      5. By Country
        1. US
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        2. Canada
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
  6. Europe Clinical Trial Supplies Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Clinical Phase
      3. By Therapeutic use
      4. By End Use
      5. By Country
        1. Germany
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        2. UK
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        3. Italy
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        4. France
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        5. Spain
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        6. Netherlands
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        7. Rest of Europe
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
  7. Asia-Pacific Clinical Trial Supplies Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Clinical Phase
      3. By Therapeutic use
      4. By End Use
      5. By Country
        1. China
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        2. India
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        3. Japan
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        4. South Korea
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        5. Australia & New Zealand
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        6. Indonesia
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        7. Malaysia
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        8. Singapore
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        9. Philippines
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        10. Vietnam
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        11. Rest of APAC
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
  8. Latin America Clinical Trial Supplies Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Clinical Phase
      3. By Therapeutic use
      4. By End Use
      5. By Country
        1. Brazil
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        2. Mexico
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        3. Argentina
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        4. Peru
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        5. Rest of LATAM
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
  9. Middle East & Africa Clinical Trial Supplies Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Clinical Phase
      3. By Therapeutic use
      4. By End Use
      5. By Country
        1. Saudi Arabia
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        2. UAE
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        3. Qatar
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        4. Kuwait
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        5. South Africa
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        6. Nigeria
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        7. Algeria
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
        8. Rest of MEA
          1. By Product
          2. By Clinical Phase
          3. By Therapeutic use
          4. By End Use
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Clinical Trial Supplies Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Clinical Trial Supplies Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Alamc Group
    2. Catalent, Inc.
    3. PCI Services
    4. Parexel International Corporation
    5. Sharp Packaging Services
    6. Biocair
    7. O&M Movianto
    8. KLIFO A/S
    9. Thermo Fisher Scientific, Inc.
    10. Movianto
    11. Sharp
    12. Catalent, Inc
    13. Bionical Ltd.
    14. Alium Medical Limited
    15. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

 

Figure 1       Global Clinical Trial Supplies Segmentation

Figure 2       Global Clinical Trial Supplies Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 5       Global Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 6       Global Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 7       Global Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 8       Global Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 9       Global Clinical Trial Supplies Market Share, By Region, By Value, 2019–2029

Figure 10     North America Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 11     North America Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 12     North America Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 13     North America Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 14     North America Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 15     North America Clinical Trial Supplies Market Share, By Country, By Value, 2019–2029

Figure 16     US Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 17     US Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 18     US Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 19     US Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 20     US Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 21     Canada Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 22     Canada Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 23     Canada Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 24     Canada Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 25     Canada Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 26     Europe Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 27     Europe Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 28     Europe Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 29     Europe Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 30     Europe Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 31     Europe Clinical Trial Supplies Market Share, By Country, By Value, 2019–2029

Figure 32     Germany Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 33     Germany Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 34     Germany Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 35     Germany Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 36     Germany Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 37     UK Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 38     UK Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 39     UK Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 40     UK Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 41     UK Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 42     Italy Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 43     Italy Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 44     Italy Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 45     Italy Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 46     Italy Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 47     France Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 48     France Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 49     France Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 50     France Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 51     France Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 52     Spain Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 53     Spain Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 54     Spain Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 55     Spain Clinical Trial Supplies Market Share, By Flow Rate, By Value, 2019–2029

Figure 56     Spain Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 57     The Netherlands Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 58     The Netherlands Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 59     The Netherlands Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 60     The Netherlands Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 61     The Netherlands Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 62     Rest of Europe Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 63     Rest of Europe Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 64     Rest of Europe Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 65     Rest of Europe Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 66     Rest of Europe Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 67     Asia-Pacific Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 68     Asia-Pacific Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 69     Asia-Pacific Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 70     Asia-Pacific Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 71     Asia-Pacific Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 72     Asia-Pacific Clinical Trial Supplies Market Share, By Country, By Value, 2019–2029

Figure 73     China Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 74     China Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 75     China Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 76     China Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 77     China Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 78     India Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 79     India Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 80     India Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 81     India Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 82     India Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 83     Japan Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 84     Japan Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 85     Japan Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 86     Japan Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 87     Japan Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 88     South Korea Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 89     South Korea Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 90     South Korea Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 91     South Korea Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 92     South Korea Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 93     Australia & New Zealand Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 94     Australia & New Zealand Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 95     Australia & New Zealand Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 96     Australia & New Zealand Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 97     Australia & New Zealand Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 98     Indonesia Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 99     Indonesia Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 100   Indonesia Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 101   Indonesia Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 102   Indonesia Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 103   Malaysia Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 104   Malaysia Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 105   Malaysia Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 106   Malaysia Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 107   Malaysia Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 108   Singapore Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 109   Singapore Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 110   Singapore Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 111   Singapore Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 112   Singapore Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 113   Philippines Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 114   Philippines Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 115   Philippines Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 116   Philippines Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 117   Philippines Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 118   Vietnam Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 119   Vietnam Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 120   Vietnam Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 121   Vietnam Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 122   Vietnam Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 123   Rest of APAC Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 124   Rest of APAC Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 125   Rest of APAC Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 126   Rest of APAC Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 127   Rest of APAC Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 128   Latin America Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 129   Latin America Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 130   Latin America Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 131   Latin America Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 132   Latin America Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 133   Latin America Clinical Trial Supplies Market Share, By Country, By Value, 2019–2029

Figure 134   Brazil Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 135   Brazil Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 136   Brazil Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 137   Brazil Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 138   Brazil Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 139   Mexico Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 140   Mexico Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 141   Mexico Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 142   Mexico Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 143   Mexico Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 144   Argentina Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 145   Argentina Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 146   Argentina Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 147   Argentina Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 148   Argentina Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 149   Peru Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 150   Peru Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 151   Peru Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 152   Peru Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 153   Peru Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 154   Rest of LATAM Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 155   Rest of LATAM Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 156   Rest of LATAM Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 157   Rest of LATAM Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 158   Rest of LATAM Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 159   Middle East & Africa Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 160   Middle East & Africa Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 161   Middle East & Africa Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 162   Middle East & Africa Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 163   Middle East & Africa Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 164   Middle East & Africa Clinical Trial Supplies Market Share, By Country, By Value, 2019–2029

Figure 165   Saudi Arabia Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 166   Saudi Arabia Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 167   Saudi Arabia Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 168   Saudi Arabia Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 169   Saudi Arabia Clinical Trial Supplies Market Share, By Distribution Channel, By Value, 2019–2029

Figure 170   UAE Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 171   UAE Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 172   UAE Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 173   UAE Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 174   UAE Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 175   Qatar Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 176   Qatar Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 177   Qatar Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 178   Qatar Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 179   Qatar Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 180   Kuwait Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 181   Kuwait Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 182   Kuwait Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 183   Kuwait Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 184   Kuwait Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 185   South Africa Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 186   South Africa Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 187   South Africa Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 188   South Africa Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 189   South Africa Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 190   Nigeria Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 191   Nigeria Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 192   Nigeria Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 193   Nigeria Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 194   Nigeria Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 195   Algeria Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 196   Algeria Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 197   Algeria Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 198   Algeria Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 199   Algeria Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

Figure 200   Rest of MEA Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Figure 201   Rest of MEA Clinical Trial Supplies Market Share, By Product, By Value, 2019–2029

Figure 202   Rest of MEA Clinical Trial Supplies Market Share, By Clinical Phase, By Value, 2019–2029

Figure 203   Rest of MEA Clinical Trial Supplies Market Share, By Therapeutic use, By Value, 2019–2029

Figure 204   Rest of MEA Clinical Trial Supplies Market Share, By End Use, By Value, 2019–2029

 

List of Tables

 

Table 1        Global Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 2        Global Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 3        Global Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 4        Global Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 5        Global Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 6        Global Clinical Trial Supplies Market Size, By Region, By Value, 2019–2029

Table 7        North America Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 8        North America Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 9        North America Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 10      North America Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 11      North America Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 12      North America Clinical Trial Supplies Market Size, By Country, By Value, 2019–2029

Table 13      US Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 14      US Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 15      US Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 16      US Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 17      US Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 18      Canada Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 19      Canada Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 20      Canada Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 21      Canada Clinical Trial Supplies Market Size, By Flow Rate, By Value, 2019–2029

Table 22      Canada Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 23      Europe Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 24      Europe Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 25      Europe Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 26      Europe Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 27      Europe Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 28      Europe Clinical Trial Supplies Market Size, By Country, By Value, 2019–2029

Table 29      Germany Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 30      Germany Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 31      Germany Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 32      Germany Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 33      Germany Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 34      UK Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 35      UK Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 36      UK Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 37      UK Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 38      UK Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 39      Italy Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 40      Italy Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 41      Italy Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 42      Italy Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 43      Italy Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 44      France Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 45      France Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 46      France Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 47      France Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 48      France Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 49      Spain Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 50      Spain Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 51      Spain Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 52      Spain Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 53      Spain Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 54      The Netherlands Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 55      The Netherlands Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 56      The Netherlands Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 57      The Netherlands Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 58      The Netherlands Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 59      Rest of Europe Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 60      Rest of Europe Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 61      Rest of Europe Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 62      Rest of Europe Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 63      Rest of Europe Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 64      Asia-Pacific Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 65      Asia-Pacific Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 66      Asia-Pacific Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 67      Asia-Pacific Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 68      Asia-Pacific Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 69      Asia-Pacific Clinical Trial Supplies Market Size, By Country, By Value, 2019–2029

Table 70      China Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 71      China Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 72      China Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 73      China Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 74      China Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 75      India Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 76      India Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 77      India Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 78      India Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 79      India Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 80      Japan Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 81      Japan Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 82      Japan Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 83      Japan Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 84      Japan Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 85      South Korea Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 86      South Korea Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 87      South Korea Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 88      South Korea Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 89      South Korea Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 90      Australia & New Zealand Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 91      Australia & New Zealand Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 92      Australia & New Zealand Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 93      Australia & New Zealand Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 94      Australia & New Zealand Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 95      Indonesia Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 96      Indonesia Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 97      Indonesia Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 98      Indonesia Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 99      Indonesia Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 100    Malaysia Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 101    Malaysia Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 102    Malaysia Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 103    Malaysia Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 104    Malaysia Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 105    Singapore Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 106    Singapore Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 107    Singapore Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 108    Singapore Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 109    Singapore Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 110    Philippines Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 111    Philippines Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 112    Philippines Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 113    Philippines Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 114    Philippines Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 115    Vietnam Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 116    Vietnam Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 117    Vietnam Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 118    Vietnam Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 119    Vietnam Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 120    Rest of APAC Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 121    Rest of APAC Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 122    Rest of APAC Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 123    Rest of APAC Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 124    Rest of APAC Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 125    Latin America Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 126    Latin America Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 127    Latin America Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 128    Latin America Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 129    Latin America Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 130    Latin America Clinical Trial Supplies Market Size, By Country, By Value, 2019–2029

Table 131    Brazil Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 132    Brazil Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 133    Brazil Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 134    Brazil Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 135    Brazil Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 136    Mexico Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 137    Mexico Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 138    Mexico Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 139    Mexico Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 140    Mexico Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 141    Argentina Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 142    Argentina Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 143    Argentina Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 144    Argentina Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 145    Argentina Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 146    Peru Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 147    Peru Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 148    Peru Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 149    Peru Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 150    Peru Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 151    Rest of LATAM Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 152    Rest of LATAM Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 153    Rest of LATAM Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 154    Rest of LATAM Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 155    Rest of LATAM Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 156    Middle East & Africa Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 157    Middle East & Africa Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 158    Middle East & Africa Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 159    Middle East & Africa Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 160    Middle East & Africa Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 161    Middle East & Africa Clinical Trial Supplies Market Size, By Country, By Value, 2019–2029

Table 162    Saudi Arabia Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 163    Saudi Arabia Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 164    Saudi Arabia Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 165    Saudi Arabia Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 166    Saudi Arabia Clinical Trial Supplies Market Size, By Distribution Channel, By Value, 2019–2029

Table 167    UAE Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 168    UAE Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 169    UAE Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 170    UAE Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 171    UAE Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 172    Qatar Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 173    Qatar Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 174    Qatar Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 175    Qatar Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 176    Qatar Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 177    Kuwait Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 178    Kuwait Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 179    Kuwait Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 180    Kuwait Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 181    Kuwait Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 182    South Africa Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 183    South Africa Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 184    South Africa Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 185    South Africa Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 186    South Africa Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 187    Nigeria Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 188    Nigeria Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 189    Nigeria Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 190    Nigeria Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 191    Nigeria Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 192    Algeria Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 193    Algeria Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 194    Algeria Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 195    Algeria Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 196    Algeria Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 197    Rest of MEA Clinical Trial Supplies Market Size, By Value (USD Million), 2019–2029

Table 198    Rest of MEA Clinical Trial Supplies Market Size, By Product, By Value, 2019–2029

Table 199    Rest of MEA Clinical Trial Supplies Market Size, By Clinical Phase, By Value, 2019–2029

Table 200    Rest of MEA Clinical Trial Supplies Market Size, By Therapeutic use, By Value, 2019–2029

Table 201    Rest of MEA Clinical Trial Supplies Market Size, By End Use, By Value, 2019–2029

Table 202    Almac Group Company Overview

Table 203    Almac Group Financial Overview

Table 204    Catalent, Inc. Company Overview

Table 205    Catalent, Inc. Financial Overview

Table 206    PCI Services Company Overview

Table 207    PCI Services Financial Overview

Table 208    Parexel International Corporation Company Overview

Table 209    Parexel International Corporation Financial Overview

Table 210    Sharp Packaging Services Company Overview

Table 211    Sharp Packaging Services Financial Overview

Table 212    Biocair Company Overview

Table 213    Biocair Financial Overview

Table 214    O&M Movianto Company Overview

Table 215    O&M Movianto Financial Overview

Table 216    KLIFO A/S Company Overview

Table 217    KLIFO A/S Financial Overview

Table 218    Thermo Fisher Scientific, Inc. Company Overview

Table 219    Thermo Fisher Scientific, Inc. Financial Overview

Table 220    Movianto Company Overview

Table 221    Movianto Financial Overview

Table 222    Sharp Company Overview

Table 223    Sharp Financial Overview

Table 224    Catalent, Inc Company Overview

Table 225    Catalent, Inc Financial Overview

Table 226    Bionical Ltd. Company Overview

Table 227    Bionical Ltd. Financial Overview

Table 228    Alium Medical Limited Company Overview

Table 229    Alium Medical Limited Financial Overview

Market Segmentation

By Product

  • Manufacturing

  • Supply Chain Management

  • Logistics

  • Storage & Distribution

  • Others

By Clinical Phase

  • Phase I

  • Phase II

  • Phase III

  • Others

By Therapeutic use

  • Oncology

  • CNS

  • Cardiovascular

  • Infectious Disease

  • Metabolic Disorders

  • Others

By End Use

  • Pharmaceutical

  • Biologics

  • Medical Device

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

By Products & Services

 

Ø  Manufacturing

Ø  Packaging

Ø  Logistics

Ø  Storage & Distribution

 

By Phase

 

Ø  Phase I

Ø  Phase II

Ø  Phase III

Ø  Phase IV

 

By Region

 

Ø  North America

Ø  Europe 

Ø  Asia Pacific

Ø  Latin America

Ø  Middle East & Africa

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: North America is expected to grow at the fastest rate in Global Clinical Trial Supplies Market during the forecast period.
Ans: Global Clinical Trial Supplies Market size was estimated at USD 2,090.2 million in 2022.
Ans: Major factors driving the growth of Global Clinical Trial Supplies Market include increasing pharmaceutical and biopharmaceutical R&D expenditures and rising burden of chronic and communicable diseases.
Ans: Key players in Global Clinical Trial Supplies Market include Alamc Group, Catalent, Inc., PCI Services, Parexel International Corporation, Sharp Packaging Services, Biocair, O&M Movianto, KLIFO A/S, Thermo Fisher Scientific, Inc., Movianto, Sharp, Catalent, Inc, Bionical Ltd., and Alium Medical Limited.
Ans: The pharmaceutical segment held the highest market share in the Global Clinical Trial Supplies Market by end use.